Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.44
30.04.23
-
30.04.24
-70.95%
01.05.24

StockNews.com 
30.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.43
30.04.23
-
30.04.24
-47.00%
01.05.24

StockNews.com 
30.04.23 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.55
22.04.23
-
22.04.24
-76.33%
23.04.24

StockNews.com 
22.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.41
22.04.23
-
22.04.24
-43.90%
23.04.24

StockNews.com 
22.04.23 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
03.04.23
-
03.04.27
-12.14%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
03.04.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.87
24.03.23
-
24.03.24
12.58%
18.05.23

Could be very worthwhile Investment >20% year
quelbe60 
24.03.23 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.77
21.03.23
-
21.03.24
-7.32%
02.04.23

Could be very worthwhile Investment >20% year
thomasw 
21.03.23 50%
sell
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.93
11.03.23
€0.30
11.03.24
-77.19%
08.07.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
geldnutzer 
11.03.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.36
05.03.23
-
05.03.24
-35.75%
06.03.24

StockNews.com 
05.03.23 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
01.03.23
€14.00
-
02.03.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
01.03.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.36
26.02.23
-
26.02.24
-35.75%
27.02.24

StockNews.com 
26.02.23 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.42
22.01.23
-
22.01.24
12.21%
05.02.23

Could be very worthwhile Investment >20% year
thomasw 
22.01.23 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
21.01.23
-
24.05.24
-
26.01.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
21.01.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.46
04.01.23
€12.00
31.12.25
63.49%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
04.01.23 60%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.55
03.01.23
-
03.01.24
78.44%
14.05.23

Could be worthwhile Investment >10% per year
bundfuture 
03.01.23 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.58
21.11.22
-
21.11.23
-85.09%
22.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Maxi_Scalibusa 
21.11.22 0%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
19.11.22
€2.00
19.11.23
-41.00%
20.11.23

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
19.11.22 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.63
19.11.22
€2.50
19.11.23
-46.91%
11.03.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
geldnutzer 
19.11.22 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.44
17.10.22
-
17.10.23
-7.41%
22.12.22

Risky Investment
bundfuture 
17.10.22 50%
sell
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.55
13.10.22
€2.30
13.10.23
42.55%
19.11.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
geldnutzer 
13.10.22 50%
sell
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.05
20.09.22
€1.80
20.09.23
36.59%
19.11.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
20.09.22 50%
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.60
07.09.22
€50.00
31.12.24
0.00%
14.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 80%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.85
24.08.22
-
24.08.23
-10.03%
03.09.22

Could be worthwhile Investment >10% per year
Vassago1 
24.08.22 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
08.08.22
-
08.08.26
-
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
08.08.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
03.08.22
€2.80
03.08.23
-14.19%
20.09.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
03.08.22 50%